Lexicon Pharmaceuticals
LXRX
#6179
Rank
โ‚น91.80 B
Marketcap
โ‚น206.67
Share price
-3.14%
Change (1 day)
267.53%
Change (1 year)

Earnings for Lexicon Pharmaceuticals (LXRX)

Earnings in 2025 (TTM): -โ‚น5.92 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company's current earnings are โ‚น70.86 Million. In 2024 the company made an earning of -โ‚น19.18 Billion a decrease over its 2023 earnings that were of -โ‚น16.95 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lexicon Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น5.92 Billion-69.16%
2024 -โ‚น19.18 Billion13.15%
2023 -โ‚น16.95 Billion73.74%
2022 -โ‚น9.76 Billion16.16%
2021 -โ‚น8.4 Billion49.82%
2020 -โ‚น5.61 Billion-147.19%
2019 โ‚น11.87 B-203.42%
2018 -โ‚น11.49 Billion-15.31%
2017 -โ‚น13.56 Billion0.2%
2016 -โ‚น13.54 Billion2920.7%
2015 -โ‚น0.45 Billion-95.33%
2014 -โ‚น9.61 Billion-3.61%
2013 -โ‚น9.97 Billion-5.52%
2012 -โ‚น10.55 Billion-4.17%
2011 -โ‚น11.01 Billion15.5%
2010 -โ‚น9.53 Billion8.36%
2009 -โ‚น8.8 Billion-4.81%
2008 -โ‚น9.24 Billion28.79%
2007 -โ‚น7.18 Billion35.71%
2006 -โ‚น5.29 Billion52.91%
2005 -โ‚น3.46 Billion-23.89%
2004 -โ‚น4.55 Billion-24.19%
2003 -โ‚น5.99 Billion-0.48%
2002 -โ‚น6.02 Billion44.12%
2001 -โ‚น4.18 Billion23.01%
2000 -โ‚น3.4 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น710.13 B-10,922.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น110.98 B-1,791.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น493.41 B-7,619.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-โ‚น51.34 Billion 682.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น15.66 B-338.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น2.63 Billion-59.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น2.23 Billion-66.11%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น36.89 B-662.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น0.91 Billion-86.16%๐Ÿ‡บ๐Ÿ‡ธ USA